[go: up one dir, main page]

MA40897A - Unité de dispositif de médicaments contenant de la quinagolide - Google Patents

Unité de dispositif de médicaments contenant de la quinagolide

Info

Publication number
MA40897A
MA40897A MA040897A MA40897A MA40897A MA 40897 A MA40897 A MA 40897A MA 040897 A MA040897 A MA 040897A MA 40897 A MA40897 A MA 40897A MA 40897 A MA40897 A MA 40897A
Authority
MA
Morocco
Prior art keywords
quinagolide
drug
poly
alkylene oxide
block copolymer
Prior art date
Application number
MA040897A
Other languages
English (en)
Other versions
MA40897B1 (fr
Inventor
Saez Joan Carles Arce
Denis Carr
Robert Cochrane
Janet Halliday
Paul Mcdonald
Axel Niclas Petri
Mohammad Qadir
Gouher Rabani
Alistair Ross
Claire Young
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51951583&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA40897(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of MA40897A publication Critical patent/MA40897A/fr
Publication of MA40897B1 publication Critical patent/MA40897B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
    • B29C48/001—Combinations of extrusion moulding with other shaping operations
    • B29C48/0021—Combinations of extrusion moulding with other shaping operations combined with joining, lining or laminating
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2033/00—Use of polymers of unsaturated acids or derivatives thereof as moulding material
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2105/00—Condition, form or state of moulded material or of the material to be shaped
    • B29K2105/0005—Condition, form or state of moulded material or of the material to be shaped containing compounding ingredients
    • B29K2105/0035—Medical or pharmaceutical agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2031/00—Other particular articles
    • B29L2031/753—Medical equipment; Accessories therefor
    • B29L2031/754—Pessaries

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Inorganic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Mechanical Engineering (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Materials For Medical Uses (AREA)

Abstract

La présente invention est basée sur l'identification d'une cohorte de copolymères séquencés de polyuréthane qui sont particulièrement adaptés pour utilisation dans des unités médicament-dispositif polymères pharmaceutiques et qui permettent un contrôle amélioré de la libération de médicament. En particulier, l'invention concerne une unité médicament-dispositif polymère comprenant un copolymère séquencé de polyuréthane pouvant être obtenu par réaction conjointement d'un poly(oxyde d'alkylène) ; un composé difonctionnel ; un isocyanate difonctionnel ; et facultativement un copolymère séquencé comprenant des blocs de poly(oxyde d'alkylène) ; et du quinagolide en tant qu'agent actif pharmaceutique. Les unités médicament-dispositif peuvent avoir une application dans le traitement et/ou la prévention de l'endométriose.
MA40897A 2014-11-07 2015-11-05 Unité de dispositif de médicaments contenant de la quinagolide MA40897B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14192372.2A EP3017809A1 (fr) 2014-11-07 2014-11-07 Unité de dispositif de médicaments contenant de la quinagolide
PCT/EP2015/075849 WO2016071466A1 (fr) 2014-11-07 2015-11-05 Unité médicament-dispositif contenant du quinagolide

Publications (2)

Publication Number Publication Date
MA40897A true MA40897A (fr) 2017-09-13
MA40897B1 MA40897B1 (fr) 2021-04-30

Family

ID=51951583

Family Applications (2)

Application Number Title Priority Date Filing Date
MA40897A MA40897B1 (fr) 2014-11-07 2015-11-05 Unité de dispositif de médicaments contenant de la quinagolide
MA056414A MA56414A (fr) 2014-11-07 2015-11-05 Unité de dispositif de médicaments contenant de la quinagolide

Family Applications After (1)

Application Number Title Priority Date Filing Date
MA056414A MA56414A (fr) 2014-11-07 2015-11-05 Unité de dispositif de médicaments contenant de la quinagolide

Country Status (34)

Country Link
US (2) US20180008535A1 (fr)
EP (3) EP3017809A1 (fr)
JP (2) JP6907120B2 (fr)
KR (1) KR102612852B1 (fr)
CN (2) CN116212032A (fr)
AR (1) AR102571A1 (fr)
AU (2) AU2015341734C1 (fr)
CA (1) CA2966473A1 (fr)
CL (1) CL2017001119A1 (fr)
CO (1) CO2017005578A2 (fr)
DK (1) DK3215118T3 (fr)
EA (2) EA033806B9 (fr)
ES (1) ES2877973T3 (fr)
HR (1) HRP20210961T1 (fr)
HU (1) HUE054951T2 (fr)
IL (1) IL252088B (fr)
JO (1) JO3561B1 (fr)
LT (1) LT3215118T (fr)
MA (2) MA40897B1 (fr)
MD (1) MD3215118T2 (fr)
MX (1) MX379298B (fr)
MY (1) MY193638A (fr)
NZ (1) NZ731763A (fr)
PH (1) PH12017550005A1 (fr)
PL (1) PL3215118T3 (fr)
PT (1) PT3215118T (fr)
RS (1) RS62018B1 (fr)
SA (1) SA517381471B1 (fr)
SG (1) SG11201703596SA (fr)
SI (1) SI3215118T1 (fr)
TN (1) TN2017000175A1 (fr)
TW (1) TWI685339B (fr)
UA (1) UA122329C2 (fr)
WO (1) WO2016071466A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020091456A1 (fr) 2018-10-31 2020-05-07 ㈜아모레퍼시픽 Structure de réseau cœur-écorce comprenant un biopolymère et composition comprenant celle-ci
KR20210069344A (ko) 2019-12-03 2021-06-11 (주)아모레퍼시픽 바이오 폴리머를 포함하는 효능물질 전달체
US20240361338A1 (en) 2021-08-31 2024-10-31 Ferring B.V. Diagnosis and treatment of ectopic endometriosis
WO2024153752A1 (fr) 2023-01-20 2024-07-25 Ferring B.V. Synthèse stéréosélective d'intermédiaires et synthèse de quinagolides
WO2025093626A1 (fr) * 2023-10-31 2025-05-08 Basf Se Procédé de production de polyuréthanes thermoplastiques

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235988A (en) 1976-12-13 1980-11-25 Imperial Chemical Industries Limited Delivery means for biologically active agents
ATE461681T1 (de) 2003-04-29 2010-04-15 Gen Hospital Corp Verfahren und vorrichtungen für die verzögerte freisetzung von mehreren arzneimitteln
CA2531640C (fr) 2003-07-10 2013-06-18 Galen (Chemicals) Limited Dispositifs d'administration de medicaments par voie intravaginale
WO2005025549A2 (fr) * 2003-09-10 2005-03-24 Noven Pharmaceuticals, Inc. Dispositif multicouche d'administration transdermique de medicaments
WO2006117608A1 (fr) 2005-04-29 2006-11-09 Ferring International Center S.A. Traitement ou prevention du syndrome d'hyperstimulation ovarienne (ohss) au moyen d'un agoniste de la dopamine
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
SA08290041B1 (ar) 2007-02-01 2012-06-05 فيرينج انترناشونال سنتر اس آيه أدوية من أجل معالجة بطانة الرحم
EP2244782A4 (fr) 2008-01-25 2011-09-14 Univ Utah Res Found Polymère à libération d'ordre linéaire
US8383152B2 (en) * 2008-01-25 2013-02-26 Gruenenthal Gmbh Pharmaceutical dosage form
US20100040671A1 (en) 2008-08-12 2010-02-18 Ahmed Salah U Intravaginal Devices With a Rigid Support, Methods of Making, and Uses Thereof
US20100210600A1 (en) * 2009-02-19 2010-08-19 Prelief Inc. Methods and Compositions for Treating Urogenital Disorders
WO2010150098A2 (fr) * 2009-06-26 2010-12-29 Ferring International Center Sa Traitement de l’endométriose
US20110262347A1 (en) * 2010-04-08 2011-10-27 The Salk Institute For Biological Studies Methods and compositions for enhanced delivery of compounds
WO2012066000A1 (fr) 2010-11-15 2012-05-24 Dsm Ip Assets B.V. Dispositif d'administration de médicament intra-vaginal comportant un copolymère polyuréthane
MX357598B (es) * 2011-07-20 2018-07-16 F Kiser Patrick Dispositivos intravaginales para administración de fármaco.
US10137199B2 (en) * 2013-05-14 2018-11-27 Biotime, Inc. Thiolated hyaluronan-based hydrogels cross-linked using oxidized glutathione
US10413504B2 (en) * 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system

Also Published As

Publication number Publication date
EA201790898A1 (ru) 2017-11-30
SG11201703596SA (en) 2017-06-29
HUE054951T2 (hu) 2021-10-28
HRP20210961T1 (hr) 2021-09-17
PT3215118T (pt) 2021-05-31
WO2016071466A1 (fr) 2016-05-12
EP3017809A1 (fr) 2016-05-11
PH12017550005A1 (en) 2017-10-18
TW201625245A (zh) 2016-07-16
ES2877973T3 (es) 2021-11-17
EP3892261A1 (fr) 2021-10-13
TN2017000175A1 (en) 2018-10-19
US20180008535A1 (en) 2018-01-11
UA122329C2 (uk) 2020-10-26
AR102571A1 (es) 2017-03-08
LT3215118T (lt) 2021-06-10
AU2015341734B2 (en) 2020-08-20
MX379298B (es) 2025-03-10
SI3215118T1 (sl) 2021-08-31
MA40897B1 (fr) 2021-04-30
US20220040094A1 (en) 2022-02-10
EA033806B1 (ru) 2019-11-27
AU2015341734A1 (en) 2017-06-01
AU2015341734C1 (en) 2020-12-17
CN116212032A (zh) 2023-06-06
KR20170080671A (ko) 2017-07-10
CL2017001119A1 (es) 2018-01-05
JP2017533272A (ja) 2017-11-09
KR102612852B1 (ko) 2023-12-11
JO3561B1 (ar) 2020-07-05
AU2020270480A1 (en) 2020-12-17
JP2021155444A (ja) 2021-10-07
CO2017005578A2 (es) 2017-08-31
IL252088B (en) 2022-04-01
EP3215118B1 (fr) 2021-03-17
MX2017005828A (es) 2017-11-13
SA517381471B1 (ar) 2022-03-06
EA201991882A2 (ru) 2020-01-31
BR112017009476A2 (pt) 2018-01-02
TWI685339B (zh) 2020-02-21
DK3215118T3 (da) 2021-06-21
EP3215118A1 (fr) 2017-09-13
CN106999422A (zh) 2017-08-01
JP6907120B2 (ja) 2021-07-21
PL3215118T3 (pl) 2021-07-26
MY193638A (en) 2022-10-21
IL252088A0 (en) 2017-07-31
EA201790898A8 (ru) 2018-01-31
NZ731763A (en) 2024-04-26
EA033806B9 (ru) 2019-12-19
CA2966473A1 (fr) 2016-05-12
RS62018B1 (sr) 2021-07-30
MA56414A (fr) 2022-05-04
MD3215118T2 (ro) 2021-08-31

Similar Documents

Publication Publication Date Title
MA40897A (fr) Unité de dispositif de médicaments contenant de la quinagolide
CA3014316C (fr) Dispositifs pour occlusion vasculaire
FR3029790B1 (fr) Microbille d'hydrogel de chitosane
MA43335B1 (fr) Compositions d'arni de transthyrétine (ttr) et procédés pour les utiliser pour le traitement ou la prévention de maladies associées à ttr
TN2019000126A1 (fr) Nouvelles compositions antivirales pour le traitement des infections liées aux coronavirus.
BR112019005615A8 (pt) Filme para um dispositivo médico ou embalagem, filme de curativo de ferida, e método de fabricação de um dispositivo médico
MX2013003892A (es) Composicion farmaceutica liquida para el suministro de ingredientes activos.
MA37809A1 (fr) Administration de médicament biodégradable pour compositions hydrophobes
MA39726A (fr) Compositions pharmaceutiques de composés thérapeutiquement actifs
MA39725B1 (fr) Compositions pharmaceutiques de composés thérapeutiquement actifs
FR3046610B1 (fr) Utilisation de 4,4-difluoro-4-bora-3a,4a-diaza-s-indacenes pour la securisation
MA31941B1 (fr) Bis-pyridylpyridones en tant qu'antagonistes du récepteur 1 de l'hormone de concentration de la mélanine
BR112022002289A2 (pt) Composições de curativo líquido e seus usos veterinários
BR112022000855A2 (pt) Moduladores de nlrp3
FR3065371B1 (fr) Composition pharmaceutique topique comprenant au moins de l'amitriptyline pour le traitement de douleurs neuropathiques peripheriques
MX2022007285A (es) Compuestos, polimeros, dispositivos y usos de los mismos.
FR3044663B1 (fr) Copolymere monofonctionnel ou telechelique de 1,3-butadiene et d'ethylene.
CR20220198A (es) Composición farmacéutica que puede usarse para la prevención y/o el tratamiento de la hemofilia a adquirida, y producto que comprende la composición farmacéutica
EP3603647A4 (fr) Composition pharmaceutique pour la prévention et le traitement du glaucome, contenant un dérivé d'adénosine
MA38871A1 (fr) Complexe lubrifiant pour la bouche
CA3010886C (fr) Compositions biophotoniques pour le traitement de plaies de la peau et des tissus mous affectés d’infections résistantes ou non résistantes ou des deux
EP4056188A4 (fr) Agent pour la prévention ou le traitement d'une arythmie et dispositif pour la prévention ou le traitement d'une arythmie
EP4306104A4 (fr) Composition pharmaceutique pour la prévention ou le traitement d'infections virales, comprenant des nanodisques polymères
TH1701002526A (th) หน่วยอุปกรณ์ส่งยาที่มีควินาโกไลด์
FR3097758B1 (fr) Dispositif Aérosol Contenant une Composition Comprenant au moins un Polyuréthane, au moins un Polymère Acrylique, au moins un Polymère Crotonique et au moins un Agent Propulseur